Camarda V - Search Results

1

A new ligand for the urotensin II receptor.

Camarda V, Guerrini R, Kostenis E, Rizzi A, Calò G, Hattenberger A, Zucchini M, Salvadori S, Regoli D. Camarda V, et al. Br J Pharmacol. 2002 Oct;137(3):311-4. doi: 10.1038/sj.bjp.0704895. Br J Pharmacol. 2002. PMID: 12237249 Free PMC article.

2

Pharmacological characterisation of novel kinin B2 receptor ligands.

Camarda V, Rizzi A, Calo G, Wirth K, Regoli D. Camarda V, et al. Can J Physiol Pharmacol. 2002 Apr;80(4):281-6. doi: 10.1139/y02-037. Can J Physiol Pharmacol. 2002. PMID: 12025962

3

[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.

Molinari S, Camarda V, Rizzi A, Marzola G, Salvadori S, Marzola E, Molinari P, McDonald J, Ko MC, Lambert DG, Calo' G, Guerrini R. Molinari S, et al. Among authors: camarda v. Br J Pharmacol. 2013 Jan;168(1):151-62. doi: 10.1111/j.1476-5381.2012.02115.x. Br J Pharmacol. 2013. PMID: 22827708 Free PMC article.

4

[Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.

Rizzi D, Rizzi A, Bigoni R, Camarda V, Marzola G, Guerrini R, De Risi C, Regoli D, Calo' G. Rizzi D, et al. Among authors: camarda v. J Pharmacol Exp Ther. 2002 Jan;300(1):57-63. doi: 10.1124/jpet.300.1.57. J Pharmacol Exp Ther. 2002. PMID: 11752097

5

Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents.

Camarda V, Rizzi A, Calò G, Gendron G, Perron SI, Kostenis E, Zamboni P, Mascoli F, Regoli D. Camarda V, et al. Naunyn Schmiedebergs Arch Pharmacol. 2002 Feb;365(2):141-9. doi: 10.1007/s00210-001-0503-0. Epub 2001 Nov 20. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 11819032

6

Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies.

Bigoni R, Rizzi D, Rizzi A, Camarda V, Guerrini R, Lambert DG, Hashiba E, Berger H, Salvadori S, Regoli D, Calo' G. Bigoni R, et al. Among authors: camarda v. Naunyn Schmiedebergs Arch Pharmacol. 2002 Jun;365(6):442-9. doi: 10.1007/s00210-002-0548-8. Epub 2002 Apr 19. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 12070757

7

Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.

Camarda V, Song W, Marzola E, Spagnol M, Guerrini R, Salvadori S, Regoli D, Thompson JP, Rowbotham DJ, Behm DJ, Douglas SA, Calo' G, Lambert DG. Camarda V, et al. Eur J Pharmacol. 2004 Sep 13;498(1-3):83-6. doi: 10.1016/j.ejphar.2004.07.089. Eur J Pharmacol. 2004. PMID: 15363979

8

Urotensin II stimulates plasma extravasation in mice via UT receptor activation.

Vergura R, Camarda V, Rizzi A, Spagnol M, Guerrini R, Calo' G, Salvadori S, Regoli D. Vergura R, et al. Among authors: camarda v. Naunyn Schmiedebergs Arch Pharmacol. 2004 Nov;370(5):347-52. doi: 10.1007/s00210-004-0991-9. Epub 2004 Oct 23. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 15526105

9

Structure-activity relationship study on human urotensin II.

Guerrini R, Camarda V, Marzola E, Arduin M, Calo G, Spagnol M, Rizzi A, Salvadori S, Regoli D. Guerrini R, et al. Among authors: camarda v. J Pept Sci. 2005 Feb;11(2):85-90. doi: 10.1002/psc.590. J Pept Sci. 2005. PMID: 15635628

10

In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803).

Camarda V, Spagnol M, Song W, Vergura R, Roth AL, Thompson JP, Rowbotham DJ, Guerrini R, Marzola E, Salvadori S, Cavanni P, Regoli D, Douglas SA, Lambert DG, Calò G. Camarda V, et al. Br J Pharmacol. 2006 Jan;147(1):92-100. doi: 10.1038/sj.bjp.0706438. Br J Pharmacol. 2006. PMID: 16273120 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters